Ola Fjellström

Human target validation of phosphoinositide 3‐kinase (PI3K)β: effects on platelets and insulin sensitivity, using AZD6482 a novel PI3Kβ inhibitor

Sven Nylander, Bengt Kull, Jan‐Arne Björkman et al. · Journal of Thrombosis and Haemostasis · 2012 · 120 citations · Full text

Molecular Pharmacology, Signal Transduction, Blood Platelet +11

Analysis of Selective Regions in the Active Sites of Human Cytochromes P450, 2C8, 2C9, 2C18, and 2C19 Homology Models Using GRID/CPCA

Marianne Ridderström, Ismael Zamora, Ola Fjellström et al. · Journal of Medicinal Chemistry · 2001 · 70 citations

Amino Acids, Active Sites, Molecular Biology +18

Involvement of the metabolic sensor GPR81 in cardiovascular control

Kristina Wallenius, Pia Thalén, Jan‐Arne Björkman et al. · JCI Insight · 2017 · 57 citations · Full text

Hypertension, Metabolic Remodeling, Gpr81 Agonism +19

Potent Fibrinolysis Inhibitor Discovered by Shape and Electrostatic Complementarity to the Drug Tranexamic Acid

Jonas Boström, Jennifer Grant, Ola Fjellström et al. · Journal of Medicinal Chemistry · 2013 · 56 citations · Full text

Drug Target, Protein-protein Interfaces, Peptide Science +20

Structural and Catalytic Properties of the Expressed and Purified NAD(H)- and NADP(H)-Binding Domains of Proton-Pumping Transhydrogenase from <i>Escherichia coli</i>

Ola Fjellström, Carina Johansson, Jan Rydström · Biochemistry · 1997 · 52 citations